Navigation Links
Penn Pharma Invests In World-Class Inventory Management System
Date:1/11/2010

PHILADELPHIA, Jan. 11 /PRNewswire/ -- Global integrated pharmaceutical manufacturer, Penn Pharma, has invested more than $566,000 in a state-of-the-art inventory management system - incorporating real time bar coding control, unprecedented levels of stock accuracy and the Penn Customer Portal. This system makes Penn Pharma one of the first companies in its class in the U.S. or Europe to provide customers with an all-encompassing, remote access global product and inventory tracking service.

"As a business, we have a large worldwide market presence, particularly in the U.S. and Japan. Our investment in this new Customer Portal not only increases product visibility for customers wishing to track their order status, materials disposition and third party shipping but also further enables Penn Pharma to compete on the global stage as a standard for best practices," said Darren Hassey, chief operating officer at Penn Pharma.

The main driver behind this investment is to make the processes within Penn Pharma completely transparent for its customers so that the company becomes a client partner rather than a supplier, providing support every step of the way.

The new Penn Customer Portal is completely secure and allows customers to remotely access and track their Penn Pharma product inventory and also materials in transit to the end destination, whether it be an investigator site or customer storage facility. The Portal provides access to real time inventory information concerning excipients, Active Pharmaceutical Ingredients,(API) packaging materials and finished products/clinical packs, 24-hours-a-day, 365-days-a-year.

Innovative links with third party shipping websites also allow customers to view dispatch information via the Portal to enable tracking of materials and finished products across the supply chain.

"Our new Customer Portal system has been fully validated by an independent specialist making us the first company in Europe, if not the world, to validate this Sage 500 ERP software package to further enhance the quality of service and compliance we provide for our customers as part of our suite of integrated formulation, analytical services, clinical trials supply and clinical / commercial manufacturing solutions," said Hassey.

About Penn Pharma

Penn Pharma is a leading provider of fully integrated and cost effective pharmaceutical development and custom manufacturing services to the international healthcare industry, whose services support a fast and effective route from clinic to market. Penn Pharma provides unparalleled service offerings developed over its 30 year trading history. Penn Pharma has offices in South Wales, the UK and the U.S. www.pennpharm.com


    PR Contact:            Corporate Contact:
    Judith Eckles          Britton Jimenez
    484-684-6717           925-787-6886
    judithe@sagefrog.com   Britton.Jimenez@Pennpharm.com
    Sagefrog Marketing     Penn Pharma

SOURCE Penn Pharma

RELATED LINKS
http://www.pennpharm.com

'/>"/>

SOURCE Penn Pharma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier this ... The former overall number one pick in the 2001 NFL Draft, to the Atlanta ... record for the most career rushing yards by a quarterback (6,109) and the most ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 2017 Halo Labs announces the launch of ... system called the Horizon at PEGS 2017 in ... system analyzes sub visible particulate matter in biopharmaceutical samples ... as early as candidate selection and pre-formulation. ... research organization Elion Labs for system validation. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
Breaking Medicine Technology: